当前位置: 首页 >> 检索结果
共有 1694 条符合本次的查询结果, 用时 6.8280382 秒

961. Prospective randomized trial comparing pressure-controlled ventilation and volume-controlled ventilation in ARDS. For the Spanish Lung Failure Collaborative Group.

作者: A Esteban.;I Alía.;F Gordo.;R de Pablo.;J Suarez.;G González.;J Blanco.
来源: Chest. 2000年117卷6期1690-6页
To compare in-hospital mortality of patients with ARDS ventilated with either pressure-controlled ventilation (PCV) or volume-controlled ventilation (VCV) with a square-wave inspiratory flow.

962. Sleep-disordered breathing and myocardial ischemia in patients with coronary artery disease.

作者: T Mooe.;K A Franklin.;U Wiklund.;T Rabben.;K Holmström.
来源: Chest. 2000年117卷6期1597-602页
To examine the occurrence of nocturnal myocardial ischemia and its relationship to sleep-disordered breathing (apneas and oxygen desaturations) in randomly selected men and women undergoing coronary angiography because of angina pectoris.

963. Amiodarone as a first-choice drug for restoring sinus rhythm in patients with atrial fibrillation: a randomized, controlled study.

作者: P E Vardas.;G E Kochiadakis.;N E Igoumenidis.;A M Tsatsakis.;E N Simantirakis.;G I Chlouverakis.
来源: Chest. 2000年117卷6期1538-45页
To investigate the efficacy and safety of amiodarone administered as the drug of first choice in the conversion of atrial fibrillation, regardless of its duration.

964. Medical cardioversion of atrial fibrillation.

作者: M A Alpert.
来源: Chest. 2000年117卷6期1529-31页

965. Utilization in COPD: patient characteristics and diagnostic evaluation.

作者: D W Mapel.;M A Picchi.;J S Hurley.;F J Frost.;H V Petersen.;V M Mapel.;D B Coultas.
来源: Chest. 2000年117卷5 Suppl 2期346S-53S页
Information on current practices of COPD diagnosis and treatment is needed to identify opportunities for improving care. This study describes the clinical characteristics and diagnostic evaluations of COPD patients in a health maintenance organization (HMO) and a university-affiliated county medical center (UMC).

966. Effects of augmented continuous positive airway pressure education and support on compliance and outcome in a Chinese population.

作者: D S Hui.;J K Chan.;D K Choy.;F W Ko.;T S Li.;R C Leung.;C K Lai.
来源: Chest. 2000年117卷5期1410-6页
To study the effects of augmentation of continuous positive airway pressure (CPAP) education and support on compliance and outcome in patients with obstructive sleep apnea (OSA).

967. The protective effect of salbutamol inhaled using different devices on methacholine bronchoconstriction.

作者: D Giannini.;A Di Franco.;E Bacci.;F L Dente.;M Taccola.;B Vagaggini.;P Paggiaro.
来源: Chest. 2000年117卷5期1319-23页
To determine the protective effect of salbutamol, 100 microg, inhaled by different devices (pressurized metered-dose inhaler [pMDI; Ventolin; GlaxoWellcome; Greenford, UK], pMDI + spacer [Volumatic; GlaxoWellcome], or breath-activated pMDI [Autohaler; 3M Pharmaceuticals; St. Paul, MN]) on bronchoconstriction induced by methacholine.

968. Salmeterol administration by metered-dose inhaler alone vs metered-dose inhaler plus valved holding chamber.

作者: K Demirkan.;E Tolley.;T Mastin.;J Soberman.;J Burbeck.;T Self.
来源: Chest. 2000年117卷5期1314-8页
To determine whether a spacer device designed as a valved holding chamber with a flow signal increases the efficacy of the long-acting beta(2)-agonist, salmeterol, in patients who use incorrect technique with metered-dose inhaler (MDI) alone.

969. Is nebulized aerosol treatment necessary in the pediatric emergency department?

作者: A Mandelberg.;S Tsehori.;S Houri.;E Gilad.;B Morag.;I E Priel.
来源: Chest. 2000年117卷5期1309-13页
Infants and small children admitted to the pediatric emergency department (PED) with acute wheezing episodes (AWE) are currently treated with nebulized wet aerosol (NWA).

970. Wet nebulization in acute asthma: the last refrain?

作者: C W Callahan.
来源: Chest. 2000年117卷5期1226-8页

971. Dose-dependent effects of mandibular advancement on pharyngeal mechanics and nocturnal oxygenation in patients with sleep-disordered breathing.

作者: J Kato.;S Isono.;A Tanaka.;T Watanabe.;D Araki.;H Tanzawa.;T Nishino.
来源: Chest. 2000年117卷4期1065-72页
To examine dose-dependent effects of mandibular advancement on collapsibility of the passive pharynx and sleep-disordered breathing (SDB).

972. Long-term effects of outpatient rehabilitation of COPD: A randomized trial.

作者: R Güell.;P Casan.;J Belda.;M Sangenis.;F Morante.;G H Guyatt.;J Sanchis.
来源: Chest. 2000年117卷4期976-83页
To examine the short- and long-term effects of an outpatient pulmonary rehabilitation program for COPD patients on dyspnea, exercise, health-related quality of life, and hospitalization rate.

973. Perception of respiratory sensation assessed by means of histamine challenge and threshold loading tests.

作者: I D Bijl-Hofland.;S G Cloosterman.;C P van Schayck.;F J v d Elshout.;R P Akkermans.;H T Folgering.
来源: Chest. 2000年117卷4期954-9页
Some asthmatic patients perceive the severity of their disease rather poorly. These patients may not receive optimal therapy because of underpresentation of their respiratory symptoms. It is therefore important to identify these patients. The present study evaluates a new threshold loading device for measuring the perception of respiratory sensation. This method for measuring the perception of respiratory sensation may be a viable alternative to the bronchial provocation test. The aim of the present study was to investigate whether the assessment of the perception of respiratory sensation based on a threshold loading test (inspiratory and expiratory) identifies the same subjects as poor perceivers as compared to assessment by histamine bronchial provocation test.

974. Additive bronchoprotective and bronchodilator effects with single doses of salmeterol and montelukast in asthmatic patients receiving inhaled corticosteroids.

作者: O J Dempsey.;A M Wilson.;E J Sims.;C Mistry.;B J Lipworth.
来源: Chest. 2000年117卷4期950-3页
We wished to evaluate whether the combination of a leukotriene receptor antagonist and long-acting beta(2)-agonist might confer additive beneficial effects in terms of bronchoprotection and bronchodilatation, in mild to moderate asthmatic patients who were suboptimally controlled on inhaled corticosteroids alone.

975. Specific inspiratory muscle training in patients with mild asthma with high consumption of inhaled beta(2)-agonists.

作者: P Weiner.;N Berar-Yanay.;A Davidovich.;R Magadle.;M Weiner.
来源: Chest. 2000年117卷3期722-7页
It has been known for many years that there are variations between asthmatic patients in terms of their perception of breathlessness during airway obstruction.

976. Demonstration of in vivo bioequivalence of a generic albuterol metered-dose inhaler to Ventolin.

作者: B A Stewart.;R C Ahrens.;S Carrier.;M Frosolono.;C Lux.;S H Han.;G Milavetz.
来源: Chest. 2000年117卷3期714-21页
To use histamine bronchoprovocation and bioassay statistical procedures to evaluate the in vivo bioequivalence of a generic albuterol metered-dose inhaler (MDI).

977. Nutritional support for individuals with COPD: a meta-analysis.

作者: I M Ferreira.;D Brooks.;Y Lacasse.;R S Goldstein.
来源: Chest. 2000年117卷3期672-8页
Malnutrition in patients with COPD is associated with an impaired pulmonary status, reduced diaphragmatic mass, lower exercise capacity, and higher mortality rate when compared to adequately nourished individuals with COPD. Nutritional support may therefore be a useful part of their comprehensive care.

978. Use of fluticasone in asthma.

作者: B J Lipworth.
来源: Chest. 2000年117卷2期611-3页

979. The effect of respiratory therapist-initiated treatment protocols on patient outcomes and resource utilization.

作者: M H Kollef.;S D Shapiro.;D Clinkscale.;L Cracchiolo.;D Clayton.;R Wilner.;L Hossin.
来源: Chest. 2000年117卷2期467-75页
Physicians frequently prescribe respiratory treatments to hospitalized patients, but the influence of such treatments on clinical outcomes is difficult to assess.

980. Low-dose budesonide with the addition of an increased dose during exacerbations is effective in long-term asthma control. On behalf of the Italian Study Group.

作者: A Foresi.;M C Morelli.;E Catena.
来源: Chest. 2000年117卷2期440-6页
This study was designed to compare the effects of a 6-month treatment with budesonide 100 microg bid (low dose) and 400 microg bid (standard reference dose) in controlling symptoms and lung function in a group of asthmatics with moderate asthma (baseline FEV(1) > or = 50% and < or = 90% of predicted values) previously treated with inhaled beclomethasone dipropionate (500 to 1,000 microg/d). Moreover, we investigated whether or not asthma exacerbations could be treated by a short-term increase in the daily dose of budesonide.
共有 1694 条符合本次的查询结果, 用时 6.8280382 秒